Satomi T, Inoue S, Fujita T, Ogawa S, Honda H, Hayashi M
Dept. of Int. Med., Kochi Municipal Hospital.
Gan No Rinsho. 1989 Mar;35(4):512-5.
OK-432 has been injected endoscopically into 4 patients with an unresectable esophageal or gastric cancer. Three months after the initial injection, a remarkable improvement in the symptoms and a reduction of the tumor size was recognized in all 4 patients. This study indicates that an OK-432 injection provides considerable benefits to patients with an advanced esophageal or gastric cancer.
Zotero 插件